These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10340170)

  • 1. Lipopolysaccharide recognition, CD14, and lipopolysaccharide receptors.
    Ingalls RR; Heine H; Lien E; Yoshimura A; Golenbock D
    Infect Dis Clin North Am; 1999 Jun; 13(2):341-53, vii. PubMed ID: 10340170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression.
    Perera PY; Mayadas TN; Takeuchi O; Akira S; Zaks-Zilberman M; Goyert SM; Vogel SN
    J Immunol; 2001 Jan; 166(1):574-81. PubMed ID: 11123339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD11/CD18 and CD14 share a common lipid A signaling pathway.
    Ingalls RR; Monks BG; Savedra R; Christ WJ; Delude RL; Medvedev AE; Espevik T; Golenbock DT
    J Immunol; 1998 Nov; 161(10):5413-20. PubMed ID: 9820516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of a novel mechanism of accelerated bacterial clearance by lipopolysaccharide in CD14-deficient and Toll-like receptor 4-deficient mice.
    Haziot A; Hijiya N; Gangloff SC; Silver J; Goyert SM
    J Immunol; 2001 Jan; 166(2):1075-8. PubMed ID: 11145687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dependence of bacterial protein adhesins on toll-like receptors for proinflammatory cytokine induction.
    Hajishengallis G; Martin M; Sojar HT; Sharma A; Schifferle RE; DeNardin E; Russell MW; Genco RJ
    Clin Diagn Lab Immunol; 2002 Mar; 9(2):403-11. PubMed ID: 11874886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial responses to endotoxins and Gram-negative bacteria.
    Heumann D; Roger T
    Clin Chim Acta; 2002 Sep; 323(1-2):59-72. PubMed ID: 12135807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD14- and Toll-like receptor-dependent activation of bladder epithelial cells by lipopolysaccharide and type 1 piliated Escherichia coli.
    Schilling JD; Martin SM; Hunstad DA; Patel KP; Mulvey MA; Justice SS; Lorenz RG; Hultgren SJ
    Infect Immun; 2003 Mar; 71(3):1470-80. PubMed ID: 12595465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipopolysaccharide interaction with cell surface Toll-like receptor 4-MD-2: higher affinity than that with MD-2 or CD14.
    Akashi S; Saitoh S; Wakabayashi Y; Kikuchi T; Takamura N; Nagai Y; Kusumoto Y; Fukase K; Kusumoto S; Adachi Y; Kosugi A; Miyake K
    J Exp Med; 2003 Oct; 198(7):1035-42. PubMed ID: 14517279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.
    Van Amersfoort ES; Van Berkel TJ; Kuiper J
    Clin Microbiol Rev; 2003 Jul; 16(3):379-414. PubMed ID: 12857774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of CD14 in cellular recognition of bacterial lipopolysaccharides.
    Kitchens RL
    Chem Immunol; 2000; 74():61-82. PubMed ID: 10608082
    [No Abstract]   [Full Text] [Related]  

  • 11. Membrane-associated proteins of a lipopolysaccharide-deficient mutant of Neisseria meningitidis activate the inflammatory response through toll-like receptor 2.
    Ingalls RR; Lien E; Golenbock DT
    Infect Immun; 2001 Apr; 69(4):2230-6. PubMed ID: 11254578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of lipopolysaccharide binding protein, CD14, and Toll-like receptors in the initiation of innate immune responses by Treponema glycolipids.
    Schröder NW; Opitz B; Lamping N; Michelsen KS; Zähringer U; Göbel UB; Schumann RR
    J Immunol; 2000 Sep; 165(5):2683-93. PubMed ID: 10946299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll receptors, CD14, and macrophage activation and deactivation by LPS.
    Dobrovolskaia MA; Vogel SN
    Microbes Infect; 2002 Jul; 4(9):903-14. PubMed ID: 12106783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist.
    Mullarkey M; Rose JR; Bristol J; Kawata T; Kimura A; Kobayashi S; Przetak M; Chow J; Gusovsky F; Christ WJ; Rossignol DP
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1093-102. PubMed ID: 12604686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unresponsiveness of MyD88-deficient mice to endotoxin.
    Kawai T; Adachi O; Ogawa T; Takeda K; Akira S
    Immunity; 1999 Jul; 11(1):115-22. PubMed ID: 10435584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression.
    Sing A; Rost D; Tvardovskaia N; Roggenkamp A; Wiedemann A; Kirschning CJ; Aepfelbacher M; Heesemann J
    J Exp Med; 2002 Oct; 196(8):1017-24. PubMed ID: 12391013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of microbial components and toll-like receptors 2 and 4 in cytokine responses to air pollution particles.
    Becker S; Fenton MJ; Soukup JM
    Am J Respir Cell Mol Biol; 2002 Nov; 27(5):611-8. PubMed ID: 12397021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble CD14-mediated cellular responses to lipopolysaccharide.
    Tapping RI; Tobias PS
    Chem Immunol; 2000; 74():108-21. PubMed ID: 10608084
    [No Abstract]   [Full Text] [Related]  

  • 19. The interaction of human peripheral blood eosinophils with bacterial lipopolysaccharide is CD14 dependent.
    Plötz SG; Lentschat A; Behrendt H; Plötz W; Hamann L; Ring J; Rietschel ET; Flad HD; Ulmer AJ
    Blood; 2001 Jan; 97(1):235-41. PubMed ID: 11133766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD14, new aspects of ligand and signal diversity.
    Landmann R; Müller B; Zimmerli W
    Microbes Infect; 2000 Mar; 2(3):295-304. PubMed ID: 10758406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.